1. "GSK Faculty"
Formats
  1. Journal Article (13834)
  2. Meeting Abstract (7076)
  3. Review (514)
  4. Book Section (342)
  5. Editorial (307)
  6. Conference Paper (162)
  7. Research Letter (96)
  8. Miscellaneous (45)
  9. Correspondence (38)
  10. Guidelines (32)
  11. Book Whole (22)
Groups
  1. GSK Faculty (22468)
  2. Sloan Kettering Institute Faculty (11482)
  3. Department of Medicine (10529)
  4. Tow Center for Developmental Oncology (TCDO) (6948)
  5. Sloan Kettering Institute Postdocs (6210)
  6. Solid Tumor Oncology Division (5880)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Steven Larson (957)
  3. Jedd Wolchok (905)
  4. Cristina Antonescu (895)
  5. Kenneth Offit (788)
  6. David Solit (779)

More People

Years
  1. 2025 (296)
  2. 2024 (868)
  3. 2023 (1016)
  4. 2022 (1152)
  5. 2021 (1088)
  6. 2020 (1257)

More Years

Publications
  1. Blood (1470)
  2. Journal of Clinical Oncology (1279)
  3. Cancer Research (1104)
  4. Clinical Cancer Research (527)
  5. Modern Pathology (494)
  6. Journal of Nuclear Medicine (474)

More Publications

Publishers
  1. Nature Publishing Group (2594)
  2. American Association for Cancer Research (2194)
  3. Elsevier Inc. (1937)
  4. American Society of Hematology (1553)
  5. Cell Press (1421)
  6. American Society of Clinical Oncology (1379)

More Publishers

Results (22468)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The genomic landscape of breast cancer in African American women
    Meeting Abstract

    Serna-Tamayo, C.; Drago, J. Z.; Dos Anjos, C.; Herbert, J.; Pareja, F.; Modi, S.; Jhaveri, K.; Dang, C.; Solit, D. B.; Norton, L.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • The genomic landscape of metastatic special histologic types of breast cancer
    Meeting Abstract

    Pareja, F.; Lee, S. S. K.; Beca, F.; Ferrando, L.; Selenica, P.; Brown, D. N.; Wen, H. Y.; Zhang, H.; Brogi, E.; Razavi, P.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Methylation profiling of mucinous breast cancer
    Meeting Abstract

    Pareja, F.; Ferrando, L.; da Silva, E. M.; Da Cruz Paula, A.; Stylianou, A.; Brown, D. N.; Selenica, P.; Serrano, J.; Wen, H. Y.; Zhang, H.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Single-cell analysis of breast cancer metastasis using patient-derived xenograft model reveals clonal relationship between primary tumor and its metastases
    Meeting Abstract

    Lee, H.; Kabeer, F.; O'Flanagan, C.; Brimhall, J.; Biele, J.; Wang, B.; Algara, T. R.; Lee, S. R.; Lai, D.; Yuen, M.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • RAD51B loss-of-function variants confer susceptibility to hereditary breast and ovarian cancers and result in tumors with genomic features of homologous recombination repair defects
    Meeting Abstract

    Mandelker, D.; Mukherjee, S.; Setton, J.; Selenica, P.; Kemel, Y.; Ceyhan-Birsoy, O.; Sheehan, M.; Tkachuk, K.; Brown, D. N.; Powell, S.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • T cell-based immunotherapy for a "public" neoantigen derived from a PIK3CA hotspot mutation
    Meeting Abstract

    Klebanoff, C.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Genomic profiling of primary and metastatic breast cancer in men
    Meeting Abstract

    Drago, J. Z.; Serna-Tamayo, C.; Dos Anjos, C. H.; Brown, D. N.; Modi, S.; Jhaveri, K.; Solit, D. B.; Traina, T. A.; Chandarlapaty, S.; Reis-Filho, J. S.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Identification of a high FOXA1-induced pro-metastatic enhancer signature in endocrine-resistant and metastatic breast cancer
    Meeting Abstract

    Fu, X.; Pereira, R.; De Angelis, C.; Nanda, S.; Qin, L.; Veeraraghavan, J.; Selenica, P.; Weigelt, B.; Reis-Filho, J. S.; Nardone, A.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Activation of the EGFR/RAS/p42,44 MAPK axis as a convergent mechanism of resistance to CDK4/6 inhibitors in ER+ breast cancer
    Meeting Abstract

    De Angelis, C.; Cataldo, M. L.; Nardone, A.; Veeraraghavan, J.; Fu, X.; Nanda, S.; Qin, L.; Sethunath, V.; Pereira, R.; Weigelt, B.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • High levels of interferon-response gene signatures are associated with de novo and acquired resistance to CDK4/6 inhibitors in ER+ breast cancer
    Meeting Abstract

    De Angelis, C.; Fu, X.; Cataldo, M. L.; Nardone, A.; Jansen, V. M.; Veeraraghavan, J.; Nanda, S.; Qin, L.; Sethunath, V.; Pereira, R.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save